NewsRoom Articles - Page 105 of 222

ThursdayOct 06, 2022 10:02 am

New Laws on Abortion May Complicate Cancer Treatment for Pregnant Patients

With abortion bans going into effect in different regions in the country, oncologists are trying to gauge how these new laws will impact treatment options for cancer patients who are pregnant. Cancer coincides with about one in every thousand pregnancies, with cancers such as leukemias, lymphomas, cervical cancer, melanoma and breast cancer being the most common. While the new abortion restrictions stipulate that exceptions based on life-threatening physical conditions and medical emergencies will be permitted, cancer physicians fear misinterpretation, noting that the legal terms remain unclear. Given that most cancer treatments and medications are toxic to growing fetuses and may…

ThursdayOct 06, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Completes Successful Phase I Clinical Trial Showing PRV-002 Concussion Drug Candidate was Safe and Well Tolerated

Odyssey Health is a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs With concussion representing a high unmet need as there is currently no FDA-approved drug, Odyssey is developing a drug formulation, PRV-002, to be administered to concussed patients; the drug candidate is currently undergoing clinical evaluation In a recent announcement, the company reported the successful completion of its Phase I clinical trial, which showed that the drug was safe and well tolerated Odyssey is looking to present the findings of the Phase I study to the FDA and is also preparing…

WednesdayOct 05, 2022 11:00 am

Study Finds Antibiotics May Boost Melanoma Growth by Depleting Gut Microbiome

New research has found that antibiotics may speed up melanoma growth in bones by weakening the body’s immune response and obstructing microbiome in the gut. Melanoma is an aggressive cancer of the skin that often spreads to a person’s bones. Once this cancer metastasizes, a patient’s five-year rate of survival drops to 30%. Gut microbiome is comprised of trillions of bacteria, fungi and viruses that live within an individual’s intestines. It is estimated that anywhere between 200 to 1,000 bacteria species exist in the gut at any given time. Studies have shown that gut microbiome composition can impact the health…

WednesdayOct 05, 2022 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Successfully Uplists, Commences Trading on the Nasdaq Market

Silo Pharma, Inc recently uplisted to the Nasdaq Capital Market, raising gross proceeds of $5 million The biopharmaceutical company has sought to merge traditional therapeutics and psychedelic research, entering into a series of joint ventures with leading medical universities to carry out research into the field Meanwhile, psychedelics are gaining increasing favour within the United States with Oregon set to begin allowing the supervised usage of psilocybin from 2023 onwards Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced that it had successfully priced its fully underwritten initial public offering,…

TuesdayOct 04, 2022 10:02 am

Frequency of Bowel Movement Could Predict Heart Attack Risk

Heart attacks are medical emergencies that occur when a blood clot hinders blood flow to an individual’s heart. Signs that you may be experiencing a heart attack include shortness of breath, chest pain and pain that travels through your body. A heart attack can be caused by a number of factors, including coronary heart disease. This illness is a major cause of death around the globe and is caused by a build-up of fatty substances in the arterial walls interrupting or blocking the supply of oxygen-rich blood to the heart. While heart disease, which is a heart attack precursor, is…

TuesdayOct 04, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Building on Safety Profile of Concussion Pharmaceutical Treatment, PRV-002, in its Phase I MAD Clinical Trial

Odyssey successfully completed the second Cohort of its Phase I MAD clinical trial, proving the safety profile of its concussion pharmaceutical treatment, PRV-002 This study built on the success of Cohort I, where the drug was well tolerated and proved safe, with no severe adverse events reported The company’s Phase I Single Ascending Dose (“SAD”) cohorts of the clinical trial closed on July 12, 2022, proving the drug was safe and well tolerated. Results from this study were well received by the SRC, who also expressed their optimism for Odyssey’s completion of the MAD portion of its Phase I trial…

MondayOct 03, 2022 10:45 am

HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues

The USPTO issued a patent for BEAT’s 12-lead electrocardiogram (“ECG”) patch monitor for detection of ACS and cardiac arrhythmia HeartBeam has developed the only 3D-vector ECG platform for heart-attack detection anytime, anywhere BEAT’s patch technology could have a disruptive effect on the ECG patch market with its ischemia detection capability News about heart attacks and other life-threatening cardiovascular issues is alarming. Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States (https://ibn.fm/FN4BR), and recent reports suggest that COVID-19 may cause heart problems (https://ibn.fm/7QAky) and that the incidence of heart…

MondayOct 03, 2022 9:48 am

Transplant Team at UW Medicine Completes Groundbreaking Surgery

Last month, the transplant team at UW Medicine completed the first successful heart transplant in the region. The surgery was coordinated by LifeCenter Northwest, an organ procurement organization. Dr. Maziar Khorsandi led the surgical team during the transplant surgery; Khorsandi is a UW Medicine surgeon who specializes in advanced heart failure and transplants as well as cardiac surgery. The transplanted heart was a donation-after-circulatory death organ. Donation-after-circulatory-death (DCD) refers to organs and tissues that have been offered for transplant after a patient is pronounced dead by a physician once their respiratory and circulatory functions have stopped. Less than 500 transplants…

FridaySep 30, 2022 11:12 am

UC San Diego Offers New Radiation Therapy That Prevents Tumor Regrowth

University of California San Diego recently began to administer a new radiation therapy for brain cancer treatment that slows down tumor regrowth and protects healthy tissue in the brain. UC San Diego neurosurgeon Marc Schwartz stated that this new therapy could help improve the quality of life of some patients and extend their lifespan. Data from the American Cancer Society shows that more than 25,000 individuals are diagnosed with malignant brain cancer in America annually. Aggressive brain tumors have a high chance of recurrence and are usually resistant to treatment. The new approach, which has been approved by the FDA,…

ThursdaySep 29, 2022 11:07 am

Breakthrough Test May Make It Easier to Diagnose Parkinson’s Using Skin Swabs

Researchers at the University of Manchester have developed a new technique to detect Parkinson’s disease. The study was based on an observation made by one individual who found out that they could distinguish Parkinson’s disease in individuals from their body odor, even before their clinical symptoms began to present. The study discovered lipids of high molecular weight that were significantly more active in individuals with Parkinson’s disease, which is a brain disorder that causes movements to be uncontrollable. This may cause stiffness, shaking and difficulty with balance and coordination. In the long term, individuals with this disorder may find it…